The Food and Drug Administration (FDA) has informed Arcadia Biosciences and Bioceres S.A. that it has completed review of the HB4 stress-tolerant soybean, which was developed by their joint venture Verdeca. USDA Surprises with Higher-Than-Expected Soybean Yield The biggest surprise in today’s USDA WASDE report was the forecast for an average U.S. soybean yield this year of 49.4 bushels/acre (3.32 MT/hectare) versus the average trade estimate of 47.5 bushels/acre (3.19 MT/hectare). As a result of the higher yield and a forecast for 88.7 million harvested acres, USDA pegged this year’s U.S. soybean production at 4.381 billion bushels (119.24 MMT). That would be the third consecutive record crop and the fourth in a row over 100 MT. Among USD...
Weighing in on strategic realignment
WPI’s team was retained by the governing board of a U.S. industry organization to review a decision, reached by vote, to invest significant assets into the development and management of an export trading company. WPI’s team conducted a formal review of this decision and concluded that the current level of market saturation would limit the benefits of the investment. Based on WPI’s analysis and recommended actions, the board subsequently reversed its decision and undertook a strategic planning effort to identify more impactful investments. On behalf of numerous clients, WPI has not only assisted in identifying strategic paths but also advised their implementation.